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Abstract 
Worldwide, 70% of the adult population has limited expression of lactase enzyme with a wide variation among differ-
ent regions and countries. Lactase deficiency may lead to lactose intolerance (LI). Depending both on the amount of 
lactose ingested and on the lactase activity, people who suffer from lactose malabsorption might experience numer-
ous gastrointestinal and extra-intestinal symptoms and manifestations. Treatment of LI mainly consists of reducing or 
eliminating lactose from the diet until the symptoms disappear as well as supplementing lactase, and inducing colon 
microbiome adaptation by probiotics. Cow’s milk is one of the major source of calcium and several other vitamins 
and minerals. Thus, a complete exclusion of dairy products may favor the development of bone diseases such as 
osteopenia and osteoporosis. Therefore, the dietetic approach has a crucial role in the management of LI patients. 
Additionally, the use of lactose and milk-derived products in non-dairy products (e.g., baked goods, breakfast cereals, 
drinks, and processed meat) has become widespread in the modern industry (the so-called “hidden lactose”). In this 
regard, a strict adherence to the lactose-free diet becomes challenging for LI patients, forced to continuous check of 
all products and food labels. In fact, lactose-free product labeling is still controversial. Considering that nowadays a 
specific cut-off value establishing “lactose-free” labeling policy is lacking and that there is no universal law regulating 
the production and commercialization of “delactosed” products, identification of specific safe and suitable products 
with a well-recognized lactose-free logo might help consumers. This narrative review aims to identify the dietary man-
agement for lactose intolerant people, avoiding symptoms and nutrients deficiencies, helped by the use of specific 
labelling to guide them to choose the safer product on the market.
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Background
Lactose intolerance (LI) occurs when the small intestine 
does not produce enough of the lactase enzyme to digest 
lactose, the sugar found in milk [1].
There is significant ambiguity regarding the terms used 
to define lactose metabolism that are often confused [2]. 
Lactose malabsorption (LM) occurs when non-digested 
lactose passes through the gut without being absorbed. 
The undigested lactose in the lumen becomes subject to 
bacterial fermentation, increasing the osmotic load and 
resulting in intolerance symptoms after lactose inges-
tion [3, 4]. When LM is coupled with the above symp-
toms, it is usually referred to as LI [2, 3]. Depending 
on both on the amount of lactose ingested and on the 
activity of the lactase, people who suffer from LM might 
experience numerous gastrointestinal symptoms, (e.g., 
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abdominal pain, bloating, borborygmi, nausea, diarrhea 
and/or constipation) and extraintestinal symptoms and 
manifestations (e.g., headache, severe fatigue, cogni-
tive dysfunction, muscle and/or joint pain, skin lesions, 
mouth ulcers, heart palpitations, eczema, urticarial and 
increased micturition). On the contrary, others might 
have no symptoms after ingestion of a standard serving 
of dairy products: 125 g for milk and yogurt, 100 g for 
fresh cheeses and 50 g for hard and aged cheeses [2, 3, 
5–8].
Approximately, 70% of the adult population worldwide 
has a limited expression of lactase enzyme, with a wide 
variation between different regions and countries [4, 9, 
10]. This condition occurs for one of two reasons: geneti-
cally determined lactase non-persistence [11] or the pres-
ence of another gastrointestinal disorders. In both cases, 
this could lead to LM and LI [12].
Nowadays, the gold standard methodology for deter-
mining LI is the  H2/CH4 Lactose Breath Test (LBT) 
coupled with the genetic test evaluating lactase-gene 
polymorphism [13]. However, diagnosis remains chal-
lenging, and the proper interpretation of different tests 
is necessary to identify the most appropriate therapeutic 
strategy [13–17].
The treatment for LI consists mainly of reducing or 
eliminating lactose from the diet until the symptoms dis-
appear. Therefore, the dietetic approach has a crucial role 
in the management of LI patients.
The right approach includes a lactose-free, or low-
lactose diet, oral lactase enzyme replacement, and colon 
microbiome adaptation, using specific probiotic strains 
with β-galactosidase enzymatic activity [7].
Lactose is commonly found in dairy products, such as 
milk, yogurt, cream, butter, ice cream, and cheese. How-
ever, lactose can also be found in some bread and baked 
foods, ready-to-eat breakfast cereals, instant soups, 
confectionery, biscuits, salad dressings, sausages, gravy, 
drink mixes, and margarine: the so-called “hidden lac-
tose”. Additionally, lactose can also be hidden in prescrip-
tion and over-the-counter medications [7].
Considering that a lactose-free diet is a key treatment 
for patients diagnosed with LI, it is essential for affected 
individuals to stay away from selected dairy products and 
non-dairy foods that contain milk and/or lactose ingredi-
ents. Therefore, it is important to pay careful attention to 
the ingredients lists of products being consumed. Words 
that indicate the presence of lactose include curds, whey, 
milk, milk by-products, dry milk solids, and milk powder.
Fortunately, individuals with LI, do not need to com-
pletely eliminate dairy products from their diet. In today’s 
market, there are excellent solutions for LI people. These 
include naturally lactose-free, and the development of 
products that rely on the hydrolysis of lactose, into glu-
cose and galactose, using the enzyme lactase.
The aim of this narrative review is to identify the best 
dietetic strategy for lactose intolerant individuals, to 
avoid symptoms and nutrient deficiency (e.g. calcium), 
helped by the use of specific labelling to guide them to 
choose the safer product on the market.
Nutritional management in LI patients
Individuals with LI are usually instructed to follow a 
lactose-free diet to reduce symptom manifestations [7]. 
However, the avoidance of all dairy products in patients 
with LI is no longer recommended today, as the majority 
of LI patients can tolerate up to 5 g of lactose per single 
dose—approximately the equivalent of 100 mL of milk. 
The tolerance threshold increases if the lactose is con-
sumed together with other nutrients. In this context, it 
would be useful to have an authoritative guide on which 
products to choose in order to not exceed the individual 
tolerability threshold of lactose [7].
This is important, as the exclusion of all dairy products 
could lead to the development of micronutrient deficien-
cies. In fact, cow’s milk and dairy products are a major 
source of calcium, phosphorus, choline, riboflavin, vita-
min B12 and vitamin A [18]. In the United States dairy 
products contribute on average 72% of calcium, 26% of 
riboflavin, 16% of vitamin A, 20% of vitamin B12, 18% of 
potassium, 16% of zinc, 15% of magnesium and 19% of 
high-quality protein [19, 20].
Moreover, two to three daily servings of dairy products 
are also part of the Mediterranean Diet and the Dietary 
Approaches to Stop Hypertension (DASH) [19, 21].
Results on nutrient intake among LI subjects show 
that, compared to tolerant people, they consume lower 
amounts of calcium, with average intake ranging from 
388 to 739 mg a day, below the Recommended Dietary 
Allowance (RDA) of 1000 mg a day [22–25]. Interest-
ingly, from observational studies it has emerged that the 
avoidance of dairy products was associated with poor 
bone health [26, 27], higher blood pressure [28] and an 
increased risk of diabetes mellitus [29].
In addition, the consumption of yogurt and/or fer-
mented milk plays a fundamental role in the health of 
the gut microbiota, due to their content in probiotics. 
A recent systematic review analyzed the potential effect 
of 8 probiotic strains (Bifidobacterium longum, Bifido-
bacterium animalis, Lactobacillus bulgaricus, Lactoba-
cillus reuteri, Lactobacillus acidophilus, Lactobacillus 
rhamnosus, Saccharomyces boulardii, and Streptococ-
cus thermophilus) to better explain the rising evidence 
that probiotic bacteria in fermented and unfermented 
milk products can be used to improve the clinical 
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symptoms of LI. In conclusion, of the 8 strains studied, 
B. animalis was among the most well-researched and 
effective strain [30].
The major risk associated with the complete elimina-
tion of dairy products from the diet, is that of develop-
ing a calcium deficiency and compromising bone health. 
Therefore, it is fundamental to ensure adequate calcium 
intake at each stage of life to build and maintain an 
healthy skeleton, especially in those with LI, who con-
sume less dietary calcium than non-LI individuals [31]. 
The best sources of dietary calcium include milk, cheese 
and dairy products, such as broccoli, collards, kale, tur-
nip greens, and fortified soy products. Other foods with 
less calcium bioavailability are fortified soymilk, sesame 
seeds, almonds, and red and white beans. Despite this, 
calcium bioavailability from plant foods can be affected 
by oxalates and phytates, which are inhibitors of calcium 
absorption. Another important calcium source is water, 
in particular, hard water that has high calcium and mag-
nesium levels derived from groundwater [32].
According to the National Medical Association, cal-
cium requirements are the same for males and females 
during the first 50  years of life (1–3  years: 700 mg Ca/
day; 4–8 years and 19–50 years: 1000 mg Ca/day), with 
the highest recommended intake during the adolescence, 
when maximal bone growth occurs (9–18 years: 1300 mg 
Ca/day). These values begin to differ with the onset of 
menopause: calcium recommended intake for women is 
increased to 1200 mg Ca/day. This value then evens out 
as both sexes reach 70 years old, with the recommended 
daily allowance set at 1200 mg Ca/day, to prevent the 
development of osteoporosis [33].
To ensure optimal bone mineralization, the American 
Academy of Pediatrics supports the use of dairy products 
in children and adolescents [34, 35]. The bone mineral 
status (BMS) seems to be genetically determined up to 
80%, with environmental factors, such as weight, physi-
cal exercise, and dietary intake of calcium and vitamin 
D, affecting it up to 20% [36]. It has been demonstrated 
that a daily milk consumption of 245 mL (a cup) is associ-
ated with increased body height (0.39 cm, 95% CI 0.29 to 
0.48) [37]. Baldan and colleagues [38] evaluated the effect 
of a lactose-free diet on the phalangeal BMS in 102 LI 
adolescents compared to that of 102 peers on a normal 
diet. In particular, the time spent on a lactose-free diet 
(4.8 ± 3.1 years) was inversely correlated to the BMS. The 
results showed that lactose-free diets did not affect the 
phalangeal BMS of LI adolescents when they consumed 
lactose-free cow’s milk; but there was still a significantly 
lower calcium intake than in the control population.
Moreover, a study by Matlik and colleagues [39] 
on self-imposed dairy restriction in young girls (10–
13 years) showed an approximate 210 mg calcium intake 
deficit compared with girls that usually consumed dairy 
products.
In addition to calcium, vitamin D, vitamin A, potas-
sium, zinc, and magnesium in dairy products are also 
important nutrients in bone formation [8]. In fact, a 
review performed by Heaney and colleagues [27], con-
sisting of both randomized and observational stud-
ies, highlighted the importance of the above mentioned 
nutrients for bone health. The majority of the analyzed 
studies concluded that dairy foods are excellent sources 
for the nutritional requirement for a proper bone status 
and that it is challenging to reach the recommended cal-
cium intake without the use of dairy products.
Lactose-free alternatives
In most cases, reducing the consumption of, or avoiding, 
lactose containing foods and drinks, and replacing them 
with lactose-free alternatives, is sufficient to control the 
symptoms of intolerance. There are several alternative 
foods and drinks options available, both artificial and 
natural, to replace milk and dairy products, including lac-
tose-free dairy products and plant-based milk food [40] 
(Table 1).
To meet the dietary calcium and high-quality protein 
requirements of LI individuals, the global dairy industry 
has developed lactose-free products using the addition 
of exogenous lactase, β-galactosidase, which pre-digests 
the lactose in milk [41]. Lactose-free dairy products allow 
lactose intolerant subjects to enjoy the taste of dairy 
without the experience of intestinal symptoms occurring 
after lactose ingestion. Furthermore, lactose hydrolysis 
has been reviewed as a sugar reduction option, as the 
hydrolysis of the lactose in milk enhances the sweetness 
of the product—the same sweetness intake as adding 2% 
sugar [42]. Lactose-free dairy is also not expected to have 
any unusual nutritional effects on the human body when 
compared to regular dairy products [41]. In particular, 
no difference was observed in the glycemic response of 
diabetes patients who consumed lactose or its digestion 
products, glucose and galactose [43].
Consequently, the broad availability, wide range, and 
the safety of lactose-free products should encourage con-
sumers to make lactose-free a preferred choice for dairy 
[18].
Milk
Lactose-free cow’s milk is available in many countries in 
different forms. Currently, there are two principal meth-
ods to produce this specific milk for intolerant individu-
als (batch and aseptic methods), and both of them use 
soluble lactase enzymes [44].
The first method is the batch process, consisting of a 
pre-hydrolysis process in which neutral lactase is added 
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to the raw milk, and usually incubated for nearly 24  h 
under moderate stirring to prevent creaming. Further-
more, this process is performed at 4–8  °C to inhibit 
microbial growth as the milk is not yet sterile. After the 
incubation, milk is pasteurized, homogenized and pack-
aged [18]. No residual enzyme activity persists in the final 
product because the enzyme is inactivated throughout 
the sterilization/pasteurization stage [18]. Enzymes for 
this process possess a high activity at low temperature 
and neutral pH and low temperature, so their dosage is 
relatively high [18].
To reduce the typical doubling of sweetness after lac-
tose hydrolysis, and restored a conventional palatability, 
ultra and nano-filtration, or chromatography techniques 
(combined with the hydrolysis of the remaining lactose) 
are used [18, 45, 46]. The result is excellent quality milk 
that tastes almost identical to regular milk.
The second method is an aseptic post-hydrolysis pro-
cess, in which the milk is sterilized using the ultra-high 
temperature (UHT) procedure. Following this, a sterile 
lactase preparation is added to the milk just before pack-
aging [18]. The lactose conversion occurs directly in the 
milk package, and, as UHT milk is often kept in quaran-
tine for almost 3 days, there is sufficient time to achieve 
the hydrolysis before the product is dispatched to the 
retailer. Since both temperature and time of incubation 
Table 1 Lactose content of common dairy foods
These are estimates only; actual lactose content may vary by specific product, brand, or recipe
Food Lactose content (g) per 100 g Ref.
Milk and derivatives
 Whole milk 4.9 http://www.bda-ieo.it [78]
 Skimmed milk 5.3 http://www.bda-ieo.it [78]
 Lactose-free milk 0.01–0.1 Churakova et al. [41]
 Goat milk 4.7 http://www.bda-ieo.it [78]
 Donkey milk 6.1 Malacarne et al. [79]
 Cooking cream 3.9 http://www.bda-ieo.it [78]
 Sour cream 3.4 https ://fdc.nal.usda.gov [80]
 Powdered milk 4.2 http://www.bda-ieo.it [78]
 Butter 1.1 http://www.bda-ieo.it [78]
 Plain yogurt 2.6 http://www.bda-ieo.it [78]
 Fruit yogurt 3.2 http://www.bda-ieo.it [78]
 Greek yogurt 0.5 http://www.bda-ieo.it [78]
 Cultured fermented milk 3.75 https ://fdc.nal.usda.gov [80]
 Cultured buttermilk 4.5 https ://fdc.nal.usda.gov [80]
Fresh cheeses
 Mozzarella cheese 0.7 http://www.bda-ieo.it [78]
 Buffalo Mozzarella 0.4 http://www.bda-ieo.it [78]
 Ricotta cheese 3.5 http://www.bda-ieo.it [78]
 Feta cheese 1.4 http://www.bda-ieo.it [78]
 Cottage cheese 3.2 http://www.bda-ieo.it [78]
 Lactose-free fresh cheeses 0.01–0.1 Dekker et al. [18]
Hard cheeses
 Cheddar 0.5 http://www.bda-ieo.it [78]
 Emmentaler PDO < 0.1 https ://www.emmen taler .ch [81]
 Gruyere PDO < 0.1 https ://gruye re.com/ [82]
 Fontina PDO 0.8 http://www.bda-ieo.it [78]
Aged cheeses
 Parmigiano Reggiano PDO < 0.01 Pecorari et al. [49]
Coppa et al. [50]
 Grana Padano PDO < 0.01 Monti et al. [51]
 Pecorino Romano < 0.01 Idda et al. [83]
Blue cheeses
 Gorgonzola PDO < 0.1 https ://www.gorgo nzola .com/ [52]
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are higher in this method, the amount of the enzyme can 
be much lower when compared to the batch process [18].
Cheese
There are many lactose-free kinds of cheese available on 
the market These cheeses are produced by incubating the 
cheese milk with lactase before renneting. This technique 
is useful mainly for young and fresh cheeses that contain 
a significant amount of lactose.
Throughout the cheese making process, the milk is 
thickened, and the curds (the solid parts) are isolated 
from the whey (the liquid part where most of the lac-
tose is). Whey is drained off before the cheese is made, 
so quite a bit of lactose is removed. The curds used to 
produce hard cheeses have less moisture (whey) than the 
curds used to make softer cheeses; therefore, soft cheeses 
possess more lactose than hard ones [18, 47].
More-extra moisture is lost as cheese ages. Moreover, 
during the aging process, in hard and matured cheeses, 
lactic acid bacteria consume all the lactose present in the 
cheese, so no lactase incubation is needed. The longer 
a cheese has been matured, the less lactose remains in 
the final product; therefore, the lactose concentration in 
hard-matured (long-ripened) cheeses is usually very low 
and can be easily tolerated by most individuals suffering 
from primary LI.
Parmigiano Reggiano PDO is an example of a hard-
matured variety of cheese; it is naturally produced with 
up to 30% water and 70% nutritious substances, espe-
cially protein, calcium and phosphorus [48].
Following the decisions of the Italian Ministry of 
Health, this is the statement that can be used on the 
labels of Parmigiano Reggiano packaging: “Parmigiano 
Reggiano is naturally lactose free. The absence of lactose 
is a natural consequence of the traditional Parmigiano 
Reggiano manufacturing process and it contains less than 
0.01  g/100  g galactose” [48]. Indeed, there are natural 
microbiological conditions for which lactose is absent 
in Parmigiano Reggiano from the early stages of cheese 
aging. Scientific investigations validate these statements. 
In a research study carried out by the Consortium, Pec-
orari et  al. demonstrated that 48  h after production, 
0.004 g/100 g of lactose are found in a wheel of Parmi-
giano Reggiano [49]. Furthermore, Coppa et  al., dem-
onstrated that Parmigiano Reggiano is free from lactose 
and, when analyzing it at different stages of maturation 
over 1 to 36 months, showed that its lactose content was 
more than one hundred times lower than the level found 
by Pecorari and others [50] (Table 1).
Similarly to Parmigiano Reggiano, Grana Padano PDO 
cheese is naturally lactose free thanks to the characteris-
tics of its production and aging process and has less than 
0.01 g/100 g residual galactose content [51] (Table 1).
The Italian Gorgonzola cheese is another naturally lac-
tose free dairy product. The lactose content in Gorgon-
zola is below the ministerial limit to define a cheese as 
“naturally lactose-free” (< 0.1 g/100 g). This result is sup-
ported by a research conducted by the Consortium for 
the Protection of Gorgonzola cheese in collaboration 
with CREA Research Center of Lodi [52] (Table 1).
Yogurt and other fermented products
Yogurt is a fermented food containing live bacteria, pro-
duced from fermented milk. It is nutritionally rich in cal-
cium, riboflavin, vitamin B6, B12, protein and probiotics 
(live microorganisms which improve the health status of 
the host by exerting beneficial effects in the gastrointesti-
nal tract [47, 53]).
Most lactose-intolerant people can eat yogurt without 
exhibiting typical symptoms; moreover, yogurt consump-
tion is suggested as a suitable dietary strategy to reach the 
recommended daily intake of calcium for LI individuals 
[54, 55]. In particular, some yogurt culture microorgan-
isms such as L. delbrueckii subsp. bulgaricus and S. ther-
mophilus are able to produce β-galactosidase as part of 
their lactose utilization pathway and can likely promote 
lactose digestion in vivo [47, 56].
Despite this, the lactose content is only partially 
reduced by the original fermentation of yogurt, and most 
of the lactose survives in the finished product (Table 1). 
When yogurt is eaten, the live organisms, which contain 
intracellular β-galactosidase, presumably survive the gas-
tric acidic environment and reach the small intestine, 
where they are permeabilized by bile acids and release 
β-galactosidase into the lumen [54, 57]. Thus, any lac-
tose is hydrolyzed by bacterial β-galactosidase, and the 
glucose and galactose are absorbed across the intestinal 
epithelium. Nevertheless, many systematic reviews have 
described that those probiotic bacteria may vary in their 
ability to improve lactose digestion and reduce maldiges-
tion symptoms [30, 54, 58, 59]. The European Food Safety 
Authority (EFSA) also examined human clinical studies 
evaluating the effectiveness of yogurt in improving lac-
tose digestion [60]. According to the expert panel, there 
is “strong evidence for the biological plausibility of the 
effect,” and sufficient proof that a cause-effect association 
existed between yogurt consumption and improved lac-
tose digestion was sufficiently proved to support a health 
claim for those yogurts containing at least  108 colony-
forming units (CFU) per gram [60].
In contrast, cultured buttermilk and sour cream con-
tain similar levels of lactose (Table 1), but, together with 
other fermented dairy products, are produced using cul-
tures of mesophilic species of Lactococcus and Leucon-
ostoc. These bacteria do not express β-galactosidase and 
metabolize lactose via a β-galactosidase-independent 
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pathway [54]; thus, lactose is not hydrolyzed, and both of 
these dairy foods are not well tolerated by lactose intoler-
ant individuals [54].
Furthermore, lactose in yogurt is seen to be better 
digested due to the decreased transit time of a viscous 
meal (such as yogurt) compared to a liquid one (such as 
milk); any extra lactase in the small intestine has more 
time to digest lactose reducing intolerance symptoms 
[18, 47, 61–63]. Other factors that appear to improve lac-
tose digestion are eating other foods as part of the same 
meal and even the choice of particular species of bacteria 
used in the yogurt-making process [18, 62].
Compared to unflavored yogurts, however, flavored 
yogurts appear to show slightly decreased lactase activity 
[18, 61] (Table 1).
Regardless of which of these effects play a significant 
role in helping LI individuals tolerate fermented milk 
products, the most reliable solution seems to be the com-
plete enzymatic digestion of lactose in yogurt by incubat-
ing the milk with lactase before pasteurization (yogurt 
from hydrolyzed milk) or adding the lactase together 
with the culture concurrently with fermentation (co-
hydrolysis). In the first option, the amount of added sugar 
can be decreased since hydrolyzed products taste sweeter 
because of the higher sweetness of the single monosac-
charides; this can result in a product with lower energy 
[18, 42, 64, 65].
Non-dairy substitutes
Dairy-free products are principally obtained from plants, 
such as rice, soy, oats, coconuts, nuts, almonds, cashews, 
hemp, etc. Nowadays, the consumption of these alterna-
tives has been on the rise, and the food sector has reacted 
by making these products more available on supermarket 
shelves [8, 66, 67].
Dairy alternatives usually have a low saturated fat con-
tent combined with a lower amount of high-quality pro-
tein, minerals and vitamins (calcium, zinc, phosphorus 
and vitamin B12) compared to cow’s milk. Until recently, 
fortified soy beverage was the second runner up to dairy 
milk [8].
When consumed as the main replacement for dairy, 
vegetable alternatives could have significant health 
implications, specifically for young children (1–8 years). 
A Canadian study reported that the consumption of 
non-dairy substitute drinks was associated with lower 
childhood height [68]. Only cow’s milk and fortified soy 
beverages are considered nutritious enough for this age 
group [69]. Protein, calcium, and vitamin D, other essen-
tial nutrients for children’s growth, could also be compro-
mised if relying on solely vegetable-based replacement 
beverages.
Moreover, the EPIC-Oxford cohort study, with more 
than 34,000 British people, evidenced that vegans, those 
individuals that exclude animal products from their diet, 
have a 30% higher risk of bone fractures when compared 
to omnivores and vegetarians (consuming dairy prod-
ucts and eggs). This was that was linked to lower calcium 
intake in vegans compared to omnivores and vegetarians 
[37]. Further research and long-term studies are required 
to better understand how cow’s milk (and dairy prod-
ucts) can be safely replaced by plant-based beverages in 
an individual’s diet to meet the recommended calcium 
intake [18]. Furthermore, much plant-based food has 
several added ingredients, including salt, sugar, honey, 
agave, cane juice, or other sweeteners, adding empty cal-
ories to the diet [8].
In conclusion, plant-based diets can be safe for bone 
health if well planned: increasing the portions of calcium-
rich plant foods and using calcium supplements (being 
careful not to exceed the upper limits).
The importance of lactose-free labelling
In the last few years, a considerable interest in lactose-
free diets as the primary treatment for those suffering 
from LI has led to a significant growth in the manufac-
ture and sale of lactose-free products and more wide-
spread interest in the health benefits to consumers. 
However, at the same time, it has become increasingly 
common within the food industry for lactose and other 
milk-derived ingredients to be used as additives in non-
dairy products. In fact, lactose powder is a common 
additive in many processed foods, due to its technologi-
cal properties, mainly enhancing the texture and flavor of 
many prepared meals. As a result, strict adherence to the 
lactose-free diet might be difficult for LI patients. There-
fore, it is essential that LI individuals constantly check 
and monitor the labels of all food and drink products 
they consume [6, 70, 71]. In particular, consumers need 
to be better educated in the terms used to describe nutri-
tional and food labelling information to completely avoid 
lactose and allow gut to heal and resolve potential nutri-
tional deficiencies and other associated symptoms.
The first tool for delivering nutrition and health infor-
mation to consumers is the food label [72]. As reported 
by the European Food Information Council (EUFIC) [73], 
the general determinants of the choice of food products 
include biological (as hunger and palatability), economi-
cal (as price and knowledge), physical (e.g., accessibility), 
social (e.g., family), and psychological (e.g., mood) fac-
tors, as well as eating disorders, attitudes, and beliefs.
To protect food allergic/intolerant consumers, Euro-
pean legislation requires the provision of allergen infor-
mation on food labels. Under European Regulation (EU) 
No. 1169/2011 [74], the presence of allergens in a food 
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product must be declared in the ingredients list. Accord-
ing to European Regulation (EU) No. 1169/2011 [74], 
milk and its derivatives—including lactose—should be 
reported on the label or in the ingredients list.
At the same time, lactose-free product labelling is still 
controversial. Nowadays, both in European and non-
European countries, there is not a universal law regulat-
ing the production and commercialization of “delactosed” 
products, defined as ‘‘lactose-free” or ‘‘low-lactose”, 
except for infant and follow-on formula in which lactose 
should be 10 mg/100 kcal [74]. Moreover, also a specific 
cut-off value establishing the “lactose-free” labelling pol-
icy is lacking, as well as the absence of official methods 
for the determination of lactose in dairy products. The 
result is the proliferation of many dairy products claim-
ing the absence or reduction of lactose (< 0.01%, < 0.1%, 
and < 0.5%) differently.
As described by Goodman et al. [75], Front-of-package 
(FOP) nutritional labels strive to give simple nutritional 
information in a more accessible position and form 
compared to the Nutrition Facts table (NFt), which is 
typically displayed on the back of the packaging [75]. It 
is even more important when the consumer has special 
nutritional needs, as in the case of specific allergies and 
intolerances.
Investigations are confirming that consumers have dif-
ficulty understanding and applying the information pro-
vided in the NFt, including identifying whether nutrient 
amounts are “high” or “low” compared to daily guidelines 
[75].
Goodman et  al. have identified several features that 
increase the effectiveness of FOP systems, including the 
use of recognizable symbols that are easy to understand 
combined with simple text descriptors [75].
Food labelling for individuals with Celiac Disease is 
a good example where a clearly designed symbol has 
helped to improve the consumer’s awareness of a safer 
choice. The widespread distribution of foods declared 
as gluten-free is now possible thanks both to a defined 
law, that clarified gluten cut-offs levels for gluten-free 
products, and a visible and easy to recognize symbol 
supported by an international association for celiac con-
sumer protection.
In Italy, the lactose-intolerant patients’ association, 
AILI (Associazione Italiana Latto-Intolleranti) has 
reported that not all consumers are aware of the spe-
cific ingredients and foods that could contain lactose, 
for example buttermilk, anhydrous butter, whey, milk 
powder, and other variants [76]. For this reason, we 
believe that there is an urgent need for a specific and 
universal logo supporting all people suffering from this 
intolerance. This will help LI individuals to quickly and 
safely identify and purchase certified lactose-free items 
when doing their food shopping. AILI has assisted in 
the creation of the first internationally registered sym-
bol that identifies and certifies lactose-free and milk-
free products, named Lfree®.
Lfree® is a symbol of assurance for lactose intolerant 
consumers as it is recognized as a European certifica-
tion mark capable of distinguishing goods and services 
in respect of specific characteristics, as described in 
Reg. EU 2015/2424. Lfree® has been developed using 
a scientific and technical policy document that identi-
fies specific standards and values required for a product 
to be certified as lactose-free or milk-free. These stand-
ards have been developed specifically for consumers 
with LI, to clearly and intuitively communicate intuitive 
and straightforward information using FOP labelling. To 
date, Lfree® is the only food brand indicating a clear and 
immediate message of safety and suitability for a milk 
and lactose-free diet. In comparison to other food labels 
for special dietary needs, Lfree® could be an equivalent 
symbol for lactose-free products as the crossed grain 
symbol is for gluten-free products, or the other common 
certifications that are used for selected subgroups of con-
sumers such as Kosher, Halal or Vegan people [77].
Conclusions
Improving food labelling is a strategy that could guide 
consumers to choose safer and healthier products. How-
ever, there is a strong need to improve the LI dietary 
approach and post-diagnosis management. Nutritional 
education for healthy choices and better understanding 
of food labels are key factors to improve awareness and 
avoid lactose-containing products, ensuring adequate 
nutritional requirements. Considering the frequent use 
of lactose in many non-dairy foods, the so-called “hid-
den lactose” (e.g., baked goods, breakfast cereals, drinks, 
salad dressings, processed meat and powdered meal 
replacements), it would be helpful to mark safe and suit-
able products with a well-recognized lactose-free logo. 
Moreover, improving the development of specific prod-
ucts for LI patients could be an excellent strategy, keep-
ing in mind the current demand, costs, needs of different 
age groups, and lifestyle changes that a consumer with a 
food allergy or intolerance will face. In conclusion, food 
labelling, as well as nutritional and sensory properties of 
lactose-free products should be maximized to meet con-
sumer’s needs.
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